Maltais, François <br/><br/>
The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease.  [electronic resource] 

 -  Therapeutic advances in respiratory disease  Dec 2012 
 - 345-61 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1753-4666 
<br/><br/><label>Standard No.: </label>10.1177/1753465812463626  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bronchodilator Agents--adverse effects<br/>Delayed-Action Preparations<br/>Dry Powder Inhalers<br/>Humans<br/>Muscarinic Antagonists--adverse effects<br/>Pulmonary Disease, Chronic Obstructive--drug therapy<br/>Receptor, Muscarinic M3--antagonists & inhibitors<br/>Scopolamine Derivatives--adverse effects<br/>Tiotropium Bromide<br/>Tropanes--adverse effects